Nov 13, 2017 12:30 pm UTC| Business
ALPHARETTA, Ga., Nov. 13, 2017 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, announced that, on...
Nov 13, 2017 12:30 pm UTC| Business
NEW YORK, Nov. 13, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Service...
Strong Fourth Quarter Propels Tyson Foods to Record Year
Nov 13, 2017 12:30 pm UTC| Business
SPRINGDALE, Ark., Nov. 13, 2017 -- Tyson Foods, Inc. (NYSE:TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson®, Jimmy Dean®, Hillshire Farm®, Ball...
FTI Consulting Appoints Leslie H. Moeller as Chairman of North and South America
Nov 13, 2017 12:30 pm UTC| Business
WASHINGTON, Nov. 13, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today announced the appointment of Leslie H. Moeller as Chairman of North and South America, effective immediately. Mr. Moeller joins FTI Consulting from...
Applied Materials to Present at Upcoming Investor Conference
Nov 13, 2017 12:30 pm UTC| Business
SANTA CLARA, Calif., Nov. 13, 2017 -- Applied Materials, Inc. announced today that Dan Durn, Senior Vice President and CFO, will participate in a question-and-answer session at the Credit Suisse Annual Technology, Media...
Reata Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial and Operating Results
Nov 13, 2017 12:30 pm UTC| Business
IRVING, Texas, Nov. 13, 2017 -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2017,...
Development of Therapeutic Monoclonal Antibody Products 2017-2021
Nov 13, 2017 12:26 pm UTC| Business
Dublin, Nov. 13, 2017 -- The "The Development of Therapeutic Monoclonal Antibody Products" report has been added to Research and Markets' offering. As the pharmaceutical market in the United States...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update